Jain Global’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,207
Closed -$3.94M 1734
2026
Q1
$3.94M Sell
17,207
-199,319
-92% -$44.7M 0.02% 537
2025
Q4
$46.2M Buy
216,526
+180,564
+502% +$37.3M 0.22% 89
2025
Q3
$7.15M Buy
+35,962
New +$6.71M 0.03% 290

Other funds holding ASND

Jain Global's ASND Position: Q2 2026 in Review

Jain Global sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 17,207 shares — an estimated $3.94M sold.

Jain Global first reported a position in ASND in Q3 2025 and held it in 3 quarters. The position peaked at $46.2M in Q4 2025. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Jain Global reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
  • Jain Global sold 17,207 Ascendis Pharma A/S shares in Q2 2026, an estimated $3.94M.
  • Jain Global first reported a position in Ascendis Pharma A/S in Q3 2025 and held it in 3 quarters.
  • Jain Global's Ascendis Pharma A/S position peaked at $46.2M in Q4 2025.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.